Showing results (481-490 of 6,760) with videos related to

Sort By:
Pageof 676
Clinical Therapeutics|October 6, 1999
The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronanM Wobig, G Bach, P Beks, et al.
Clinical Therapeutics|October 6, 1999
Lack of mutual pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxin in healthy normocholesterolemic volunteersP Weber, J T Lettieri, L Kaiser, et al.
Clinical Therapeutics|October 6, 1999
An economic analysis of antimicrobial prophylaxis against urinary tract infection in patients undergoing transurethral resection of the prostateG G Liu, T Nguyen, M B Nichol
Clinical Therapeutics|August 10, 2000
A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomyM Vetrugno, A Maineo, G M Quaranta, et al.
Clinical Therapeutics|November 24, 1999
Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trialK Malmstrom, S Daniels, P Kotey, et al.
Clinical Therapeutics|November 24, 1999
Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study GroupT Burke, C Villanueva, H Mariano, et al.
Clinical Therapeutics|November 24, 1999
Prevalence of potential proton-pump inhibitor drug interactions: a retrospective review of prescriptions in community pharmaciesE Saltiel, A Fask
Clinical Therapeutics|June 27, 2000
Amprenavir: a new human immunodeficiency virus type 1 protease inhibitorH B Fung, H L Kirschenbaum, R Hameed
Clinical Therapeutics|June 27, 2000
Loratadine versus cetirizine: assessment of somnolence and motivation during the workdayL M Salmun, D Gates, M Scharf, et al.
Clinical Therapeutics|June 27, 2000
The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 yearsL M Salmun, J M Herron, C Banfield, et al.
Pageof 676